Episodes

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Orfan, President at Sharp. Kevin has been in the pharmaceutical and medical device industry for over 30 years and has incredible experience in the contract manufacturing space. He began his pharma career at Abbott …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey Kiplinger, Co-Founder of Cohere Business Strategies and advisor and coach for entrepreneurs in the life sciences space. Jeffrey Co-Founded Research Operations Group in 2000, founded Averica Discovery Services in 2007, and has over 35 …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA). Previous to launching PBOA in 2014, Gil helped launch Contract Pharma in 1999 and served as the founding editor for 15 years. …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dexter Tjoa, CEO at Tjoapack. With a master’s from Oxford University, Dexter joined Tjoapack about 5 years ago. His career has accelerated at an incredible speed since taking over the family business from his father, …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bobby Sheng, CEO and Chairman of Bora Pharmaceuticals. A California native and an experienced leader in the pharmaceutical industry, Bobby is skilled in international business, management, mergers & acquisitions, finance, and marketing. He graduated from …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with John Ross, President at Mayne Pharma US. John Ross has spent 15 years in the pharma contract services space in senior roles following some time at Eli Lilly and PWC. He joined Mayne in 2013 …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Quirmbach, Group Chief Executive Officer and President at Corden Pharma. Michael has been in the contract services space for 20 years. He joined Corden Pharma in 2014, holding positions as Vice President, Marketing and …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Eugene Ciolfi aka ‘Gene’, President and CEO at MedPharm. Gene has spent over 30 years in the CDMO space working for several renowned companies in senior roles along the way. It’s fair to say Gene …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Detlef Behrens, founder at Bay Pharma. A PhD pharmacist by training, Detlef is a seasoned industry professional having spent 20 years in the pharmaceutical and biotechnology space. He’s worked for several global CDMOs and now …